Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

注射用醋酸地加瑞克 - NMPA Drug Approval Details

Approvals/NMPA/Degarelix Acetate for Injection

Approved

化学药品

Degarelix Acetate for Injection

Ferring Pharmaceuticals A/S🇨🇳 National Medical Products Administration

Approval Date: Mar 1, 2024
Approval ID: 8bLXjFvdrMK
Company: Ferring Pharmaceuticals A/S
Type: 化学药品

Approval Details

Approval Id: 8bLXjFvdrMK
Approval Number: 国药准字HJ20180054
Generic Name: 注射用醋酸地加瑞克
Generic Name En: Degarelix Acetate for Injection
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 80mg(按地加瑞克(C₈₂H₁₀₃N₁₈O₁₆Cl)计算)
Reg Date: 2024-03-01
Expired Date: 2029-02-28
Company Name: Ferring Pharmaceuticals A/S
Production Company Name: Ferring GmbH
Company Detail Path: /organization/ferring-pharmaceuticals-a-s
Production Company Detail Path: /organization/ferring-gmbh

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 1, 2024

Approval ID

8bLXjFvdrMK

Type

化学药品

Back to NMPA Approvals